Endeavor

CAR T Effective as First-Line Therapy for High-Risk Lymphoma Patients

New three-year data from the phase 2 ZUMA-12 trial finds durable responses

New Study Shows Promise in Equalizing Outcomes for Transplant Patients

Post-transplant drug has potential to close racial gap for mismatched donors

Identifying Inflammatory Markers Related to Toxicities Early Can Improve Multiple Myeloma Treatment

Understanding the immune landscape of CAR T-related toxicities and responses can improve outcomes

Already Approved Drug Shows Promise in Patients with MDS/MPN Overlapping Syndromes

Moffitt launched trial investigates myelofibrosis drug in rare patient population

Looking at Guided Radiation for Triple-Negative Breast Cancer

A new study personalizes radiation therapy doses for patients based on their tumor profile

Using Contemporary Data to Better Classify Blood Clot Risk in Polycythemia Vera Patients

Study shows age is less of a factor than medical history when it comes to risk for thrombosis

Special Recognition for the Specialty Pharmacy

New accreditations open doors to reduce medication costs for patients

Eat This, Not That, This Holiday Season

Consider these healthier choices when it comes to prepping for your holiday meals

Arts in Medicine Celebrates 25 Years

What started as a single art cart is now a comprehensive service for patients, families and staff